Enjoy complimentary customisation on priority with our Enterprise License!
The human platelet lysate market size is forecast to increase by USD 11.06 thousand at a CAGR of 3.64% between 2023 and 2028.
The market is witnessing significant growth due to its increasing utilization in various biomedical research areas, including regenerative medicine, stem cell research, and tissue engineering. Platelet lysates are derived from human platelets and contain a rich source of growth factors, cytokines, and other bioactive molecules that play crucial roles in cellular proliferation, differentiation, and healing. Safety and efficiency are key considerations in the use of human platelet lysates. Traditional cell culture techniques rely heavily on Fetal Bovine Serum (FBS), which can pose safety concerns due to potential contaminants and variability in batch-to-batch performance.
Furthermore, the market for these lysates is expected to grow as researchers continue to explore their applications in biotechnology and healthcare facilities. Two types of human platelet lysates are available in the market: heparin-based and heparin-free. Heparin-based lysates have been the traditional choice due to their ease of preparation and availability. However, heparin-free lysates offer advantages such as improved cell performance and reduced risk of contamination, making them an increasingly popular alternative. In conclusion, the market is an essential component of the biomedical research landscape. Its applications in regenerative medicine, stem cell research, tissue engineering, and treatments for chronic diseases and neurodegenerative disorders make it a valuable tool for researchers and healthcare professionals.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD thousand" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The heparin free human platelet lysate segment is estimated to witness significant growth during the forecast period. Human Platelet Lysate (HPL), a specialized supplement derived from human platelets, is gaining popularity in various research and clinical applications due to its heparin-free composition. Unlike traditional platelet lysates that contain heparin, an anticoagulant used for blood clotting prevention, HPL does not include this compound. This feature is essential for applications where heparin may interfere with cell cultures and therapeutic products' functionality. By eliminating heparin, researchers can minimize potential interactions and confounding variables that could impact cell behavior and experimental outcomes.
Furthermore, this heparin-free HPL is beneficial for various disease indications, including tissue repair and cellular integrity, and is widely used in cell culture systems for bioactive compounds and cellular proliferation in biomedical research. Manufacturers and distributors play a crucial role in providing high-quality HPL to meet the increasing demand in the market.
Get a glance at the market share of various segments Request Free Sample
The Heparin free human platelet lysate segment accounted for USD 31,441.60 in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The North American market for human platelet lysate is experiencing expansion due to the significant investment from the US and Canadian governments in biomedical research and regenerative medicine. The US, in particular, presents a lucrative investment opportunity within North America. This is largely due to the financial support from organizations like the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA), which fund small-scale industries and companies focused on innovative product development. Furthermore, BARDA, an agency under the Department of Health and Human Services (HHS), is actively collaborating with other organizations to advance the production of Cell Therapy products.
Furthermore, safety and efficiency are paramount considerations in the market. Fetal bovine serum (FBS), a traditional additive in cell culture techniques, has ethical considerations and inconsistencies in its supply. Human platelet lysate, derived from human blood, offers a safer and more consistent alternative. Additionally, the inclusion of cytokines in human platelet lysate enhances cell growth and differentiation, making it an ideal choice for various applications, including research on neurodegenerative disorders such as Parkinson's disease. In conclusion, the North American market for human platelet lysate is poised for growth due to the increased government funding and the focus on developing novel cell therapy products. The advantages of human platelet lysate, such as safety, efficiency, and the presence of cytokines, make it a preferred choice for researchers in the biomedical field.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Rising prevalence of chronic diseases is the key driver of the market. Chronic noncommunicable diseases continue to pose a significant health challenge worldwide. These conditions, including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, are characterized by their long-term nature and are influenced by a combination of genetic, physiological, environmental, and behavioral factors. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of chronic disease-related fatalities, accounting for approximately 17.9 million deaths annually. This alarming trend has fueled the demand for innovative therapeutic solutions, leading to a swell in the market. Human platelet lysate is a valuable component in the fields of tissue engineering and cell therapy.
Furthermore, it plays a crucial role in promoting wound healing and enhancing the efficacy of stem cell therapy. With the regulatory landscape becoming increasingly favorable for biotechnology-based treatments, clinical trials using heparin-free human platelet lysate are on the rise. This trend is expected to continue as researchers and healthcare providers seek effective therapeutic options for managing chronic diseases. The therapeutic potential of human platelet lysate in addressing chronic diseases is significant. Its ability to stimulate cell growth and promote tissue regeneration makes it an attractive option for treating various conditions. As clinical trials progress and regulatory approvals are granted, the market for human platelet lysate is poised for substantial growth.
Growing investments in stem cell research is the upcoming trend in the market. Human platelet lysate is gaining significant traction in the scientific community due to its role in enhancing cell performance during stem cell research. This market growth can be attributed to the increasing focus on advancing cellular proliferation and differential potential in various healthcare applications. Platelet-derived growth factors present in human platelet lysate are crucial for promoting cell growth and development. For instance, pharmaceutical companies and healthcare facilities are leveraging this supplement to improve the efficiency of their stem cell platforms. In the realm of infectious diseases, heparin-based human platelet lysate has emerged as a preferred choice for researchers due to its compatibility with human cells and its ability to provide reproducible results.
Furthermore, investments in stem cell research continue to rise, with organizations like the California Institute for Regenerative Medicine (CIRM) allocating substantial funds towards this area. On April 27, 2023, CIRM approved a USD 89 million investment in stem cell and gene therapy research, underscoring the importance of reliable cell culture supplements like human platelet lysate in driving scientific breakthroughs. In conclusion, the market is poised for growth due to its role in supporting efficient cellular proliferation and promoting cellular differentiation in various healthcare applications. With the increasing focus on stem cell research and the need for reproducible results, human platelet lysate is expected to remain a preferred choice for researchers and pharmaceutical companies alike.
Stringent regulations and quality control requirements for human-derived products is a key challenge affecting the market growth. The market faces intricate regulatory challenges, influencing both product development and commercialization. Strict regulatory frameworks aim to maintain safety, efficacy, and quality, posing a considerable hurdle for manufacturers. In the US, the Food and Drug Administration (FDA) sets stringent guidelines for the procurement, processing, and testing of human-derived products to prevent contamination and ensure safety.
Furthermore, the European Medicines Agency (EMA) requires extensive documentation and adherence to Good Manufacturing Practice (GMP) regulations, which can be time-consuming and costly. These regulatory requirements are essential for ensuring the highest standards in cancer therapy, clinical applications, and other fields, such as mesenchymal stem cells, angiogenesis, fibroblast proliferation, and extracellular matrix production, which utilize human platelet lysate in cell culture. Companies in the market may need to secure patent license agreements to protect their intellectual property and maintain a competitive edge.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
BioLife Solutions Inc: The company offers human platelet lysate supplements such as Stimulate, Pathogen-Reduced Human Platelet Lysate nLiven PR, and T-Liven PR.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is a significant segment in the biotechnology industry, playing a crucial role in the advancement of regenerative medicine, tissue engineering, and cell therapy. This market caters to the demand for standardized, safe, and efficient solutions for various clinical applications. Platelet lysates are rich in bioactive compounds such as platelet-derived growth factors, cytokines, and other essential proteins that promote cellular proliferation, fibroblast proliferation, extracellular matrix production, and angiogenesis. The regulatory landscape for human platelet lysate is stringent due to ethical considerations and safety concerns. Heparin-free hPL is gaining popularity due to its advantages over heparin-based hPL in terms of safety and efficiency.
Furthermore, the market serves various disease indications, including Neurodegenerative Disorders like Parkinson's disease, chronic diseases, and infectious diseases. Pharmaceutical and healthcare facilities, as well as research institutions, are the primary consumers of human platelet lysate. The market offers high-quality solutions for cell culture systems, manufacture, and distribution of blood components. Platelets are essential for clotting and tissue repair, making human platelet lysate an active ingredient in innovative treatments for osteoarthritis, cartilage regeneration, hair regrowth, and more. Biogelx, a stem cell platform, is one of the leading players in the market, offering a tailored strategy to meet the specific needs of orthopedic surgeons, dermatologists, hair transplant clinics, and other healthcare professionals. The market faces manufacturing obstacles and safety regulations due to the contagious diseases risk associated with blood components. Despite these challenges, the market continues to innovate, driving the development of personalized treatment options and drug discovery in cell-based therapeutics.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
201 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.64% |
|
Market growth 2024-2028 |
USD 11.06 thousand |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
3.48 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 43% |
|
Key countries |
US, UK, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Amerigo Scientific, AventaCell BioMedical Corp. Ltd., BioLife Solutions Inc., Compass Biomedical Inc., Creative Biolabs, GeminiBio, Macopharma SA, Merck KGaA, Mill Creek Life Sciences Inc., MP Biomedicals Inc., PAN-Biotech GmbH, PL BioScience GmbH, Regenexx Des Moines, Sartorius AG, Sartorius CellGenix GmbH, Serana Europe GmbH, STEMCELL Technologies Inc., TCS Biosciences Ltd., TRINOVA BIOCHEM GmbH, and ZenBio Inc. |
|
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
|
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Technavio Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by Application
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
